Monsanto Shareowners Approve Merger with Bayer

The Bayer - Monsanto merger is in progress, shareholder approval is confirmed, and the total asset sale is estimated at $ 2.5 billion. Early this year, the cards congratulated the merger in the beginning of January 2017 at a meeting with Monsanto and Bayer CEO. It is not a company that only Monsanto and Bayer are involved with. Dow Chemical has acquired DuPont and its impact is very big. If Bayer-Monsanto reaches an agreement, the resulting company will have 29% of the global seed market and 25% of the world's pesticide market. Dow Chemical and Du Pont dominate 41% of corn and 38% of the share of the soybean seed market. If both transactions are realized, the seed market of corn and soy will actually become a duo. Basically, the vast majority of breeding plants for genetically modified crops are owned by only two large companies.

We are still waiting for their approval, and the merger of Bayer - Monsanto is considered to be the largest and most expensive merger in economic history. The German pharmaceutical group, Bayer and America's agribusiness monsanto, agreed to buy Bayer merger with an amazing $ 66 billion. This is a question to ask, for pharmaceuticals and agriculture, they are intertwined and stronger than ever. Before becoming a worldwide powerhouse, Monsanto opened in St. Louis, Missouri in 1901. It is owned by John F. Queeny. In a sixth grade education, Queeny invested in his own business and sold German artificial sweetener called Saccharin. He phoned Monsanto Chemical Factory with his wife's maiden name.